Patents by Inventor Clementina Elvezia Anna Cocuzza

Clementina Elvezia Anna Cocuzza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,2,4-Oxadiazol compounds active against gram-positive pathogens
    Patent number: 9920039
    Abstract: The present invention relates to new oxazolidinone compounds of general formula (I) having antibiotic activity even against multiresistant bacterial strains (I).
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: March 20, 2018
    Assignees: UNIVERSITÀ DEGLI STUDI DI MILANO—BICOCCA, ISTITUTO EURO MEDITERRANEO DI SCIENZA E TECNOLOGIA
    Inventors: Rosario Musumeci, Clementina Elvezia Anna Cocuzza, Cosimo Gianluca Fortuna, Andrea Pace, Antonio Palumbo Piccionello
  • 1,2,4-oxadiazol compounds active against gram-positive pathogens
    Patent number: 9862710
    Abstract: The present invention relates to novel oxazolidinone compounds of general formula (I) having antibiotic activity also against multiresistant bacterial strains.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 9, 2018
    Assignees: ISTITUTO EURO MEDITERRANEO DI SCIENZA E TECNOLOGIA, UNIVERSITA' DEGLI STUDI DI MILANO—BICOCCA
    Inventors: Rosario Musumeci, Clementina Elvezia Anna Cocuzza, Cosimo Gianluca Fortuna, Andrea Pace, Antonio Palumbo Piccionello
  • NOVEL 1,2,4-OXADIAZOL COMPOUNDS ACTIVE AGAINST GRAM-POSITIVE PATHOGENS
    Publication number: 20160297807
    Abstract: The present invention relates to new oxazolidinone compounds of general formula (I) having antibiotic activity even against multiresistant bacterial strains (I).
    Type: Application
    Filed: March 17, 2014
    Publication date: October 13, 2016
    Inventors: Rosario MUSUMECI, Clementina Elvezia Anna COCUZZA, Cosimo Gianluca FORTUNA, Andrea PACE, Antonio PALUMBO PICCIONELLO
  • IDENTIFICATION AND QUANTIFICATION OF ONCOGENIC HPV NUCLEIC ACIDS BY MEANS OF REAL-TIME PCR ASSAYS
    Publication number: 20100184053
    Abstract: Method for the identification and quantification of oncogenic HPV nucleic acids comprising: a) first line screening by means of 5 independent SYBR Green I Real-time PCR assays to determine the total viral load and to identify the presence of one or more of 13 high risk HPV genotypes in the sample; b) second line assays to be applied to samples positives for: 5 independent TaqMan Real-time PCR assays to determine the presence and the viral load of the most common oncogenic HPV types: HPV types: 16, 18, 31, 45, 33 group (including 33, 52, 58, 67 genotypes).6 independent SYBR Green I RT Real-time PCR assays to determine the presence in the sample of the oncogenic transcripts E6/E7 of HPV types 16, 18, 31, 33, 45, 58.
    Type: Application
    Filed: May 29, 2008
    Publication date: July 22, 2010
    Applicant: UNIVERSITA DEGLI STUDI DI MILANOP-BICOCCA
    Inventors: Clementina Elvezia Anna Cocuzza, Francesco Broccolo